Reversal of IFN-γ, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy-Reference-Cited by-同舟云学术

Reversal of IFN-γ, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy

Published:2008-09 Issue:9 Volume:10 Page:861-868
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Forster Olaf¹,Hilfiker-Kleiner Denise²,Ansari Aftab A.³,Sundstrom J. Bruce³,Libhaber Elena¹,Tshani Winnie¹,Becker Anthony¹,Yip Anthony¹,Klein Gunnar²,Sliwa Karen¹

Affiliation:

1. Department of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand; Soweto Cardiovascular Research Unit; Johannesburg South Africa

2. Department of Cardiology and Angiology Medical School Hannover; Germany

3. Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review;Pearson;Jama,2000

2. Peripartum cardiomyopathy;Sliwa;Lancet,2006

3. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy;Sliwa;Eur J Heart Fail,2002

4. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients;Sliwa;Eur Heart J,2006

5. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy;Hilfiker-Kleiner;Cell,2007

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine in peripartum cardiomyopathy: advancing diagnosis and management through genomic and phenotypic integration;Annals of Medicine & Surgery;2024-07-01

2. Interferons and interferon-related pathways in heart disease;Frontiers in Cardiovascular Medicine;2024-04-11

3. Biomarkers in Peripartum Cardiomyopathy—What We Know and What Is Still to Be Found;Biomolecules;2024-01-12

4. Proteomic Profiling in Patients With Peripartum Cardiomyopathy;JACC: Heart Failure;2023-12

5. NT-proBNP—Possible Prognostic Marker in Pregnant Patients with Associated Cardiovascular Risk Factors and SARS-CoV-2 Infection;Diagnostics;2023-09-23